Home / Cancer and immune system / Sorafenib
ATC L01EX02 · Antineoplastic Agents
Sorafenib shortage
As of 31 Oct 2026, Sorafenib has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 5 products.
Countries3/5
Products5packs or presentations
Short since31 Jan 20233.7 years ago
Earliest return29 Nov 2026company estimate
No return date3products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | SORAFENIB ZENTIVA | ZENTIVA ITALIA S.R.L. | 31 Jan 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | SORAFENIB MYLAN announced | MYLAN S.P.A. | 2 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | SORAFENIB ACCORD 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 112 comprimidos | Accord Healthcare S.L.U. | 3 Sep 2026 | 29 Nov 2026 | Not stated |
| BE | Sorafenib Sandoz 200 mg film-coat. tabl. 112 (112 x 1) UD | Sandoz | 7 Jul 2026 | 11 Dec 2026 | Manufacturing problem Delay in production |
| BE | Sorafenib EG 200 mg film-coat. tabl. 112 | EG | 28 Sep 2026 | not given | Increased demand |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.